230 related articles for article (PubMed ID: 28783177)
21. Analysis of soluble factors in conditioned media derived from primary cultures of cirrhotic liver of biliary atresia.
Yamazaki T; Wakai M; Enosawa S; Tokiwa T
In Vitro Cell Dev Biol Anim; 2017 Jun; 53(6):564-573. PubMed ID: 28364348
[TBL] [Abstract][Full Text] [Related]
22. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
[TBL] [Abstract][Full Text] [Related]
23. Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet.
Nakanishi C; Moriuchi A; Ido A; Numata M; Kim ID; Kusumoto K; Hasuike S; Abe H; Nagata K; Akiyama Y; Uto H; Kataoka H; Tsubouchi H
Oncol Rep; 2006 Jul; 16(1):25-31. PubMed ID: 16786119
[TBL] [Abstract][Full Text] [Related]
24. A critical role of autophagy in regulating the mesenchymal transition of ductular cells in liver cirrhosis.
Hung TM; Huang YJ; Lin YC; Chen YH; Wu YM; Lee PH
Sci Rep; 2019 Jul; 9(1):10673. PubMed ID: 31337842
[TBL] [Abstract][Full Text] [Related]
25. Increased Autophagy Markers Are Associated with Ductular Reaction during the Development of Cirrhosis.
Hung TM; Yuan RH; Huang WP; Chen YH; Lin YC; Lin CW; Lai HS; Lee PH
Am J Pathol; 2015 Sep; 185(9):2454-67. PubMed ID: 26158232
[TBL] [Abstract][Full Text] [Related]
26. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
Yu Y; Merlino G
Cancer Res; 2002 May; 62(10):2951-6. PubMed ID: 12019177
[TBL] [Abstract][Full Text] [Related]
27. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
[TBL] [Abstract][Full Text] [Related]
28. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.
Takami T; Kaposi-Novak P; Uchida K; Gomez-Quiroz LE; Conner EA; Factor VM; Thorgeirsson SS
Cancer Res; 2007 Oct; 67(20):9844-51. PubMed ID: 17942915
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
31. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
32. Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.
Lau EY; Lo J; Cheng BY; Ma MK; Lee JM; Ng JK; Chai S; Lin CH; Tsang SY; Ma S; Ng IO; Lee TK
Cell Rep; 2016 May; 15(6):1175-89. PubMed ID: 27134167
[TBL] [Abstract][Full Text] [Related]
33. miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.
Hongdan L; Feng L
Biochem Biophys Res Commun; 2018 Feb; 496(2):302-308. PubMed ID: 29307822
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats.
Sobrevals L; Rodriguez C; Romero-Trevejo JL; Gondi G; Monreal I; Pañeda A; Juanarena N; Arcelus S; Razquin N; Guembe L; González-Aseguinolaza G; Prieto J; Fortes P
Hepatology; 2010 Mar; 51(3):912-21. PubMed ID: 20198635
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis.
Cramer T; Schuppan D; Bauer M; Pfander D; Neuhaus P; Herbst H
Liver Int; 2004 Aug; 24(4):335-44. PubMed ID: 15287857
[TBL] [Abstract][Full Text] [Related]
36. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR.
Hata J; Ikeda E; Uno H; Asano S
J Histochem Cytochem; 2002 Nov; 50(11):1461-8. PubMed ID: 12417611
[TBL] [Abstract][Full Text] [Related]
38. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy for liver cirrhosis.
Fujimoto J
J Gastroenterol Hepatol; 2000 Mar; 15 Suppl():D33-6. PubMed ID: 10759218
[TBL] [Abstract][Full Text] [Related]
40. Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis.
Kaido T; Oe H; Yoshikawa A; Okajima A; Imamura M
Hepatogastroenterology; 2004; 51(56):547-51. PubMed ID: 15086199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
